News from allergan plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 08, 2020, 16:20 ET AbbVie Inc. Completes Acquisition of Allergan plc

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF...

May 07, 2020, 09:00 ET The Allergan Foundation Doubles its COVID-19 Response Donations to $4.0 Million

Allergan plc (NYSE: AGN) today announced that The Allergan Foundation has fast-tracked another $2 million dollars in charitable grants for community...

May 06, 2020, 06:55 ET Announcement relating to the outcome of the Court Sanction Hearing

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF...

Apr 28, 2020, 16:30 ET Announcement relating to the voluntary delisting of Allergan Notes

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF...

Apr 02, 2020, 07:30 ET China Gives Greenlight to Allergan's XEN® Registration for the Surgical Management of Refractory Glaucoma

Allergan plc (NYSE: AGN) today announced China's National Medical Products Administration (NMPA) approved the registration of Allergan's XEN® Gel...

Mar 31, 2020, 10:05 ET Allergan Earns ENERGY STAR® Partner of the Year - Sustained Excellence Award for the Seventh Consecutive Year

Allergan plc (NYSE: AGN) today announced it has received the ENERGY STAR® Partner of the Year Sustained Excellence Award for 2020, marking the...

Mar 30, 2020, 09:40 ET The Allergan Foundation Donates $2.0 Million to Community Organizations on Front-Line of COVID-19 Response

Allergan plc (NYSE: AGN) today announced that The Allergan Foundation has awarded approximately $13 million in charitable grants in 2020 as part of...

Mar 18, 2020, 07:30 ET Allergan Declares Second Quarter 2020 Cash Dividend of $0.74 Per Ordinary Share

Allergan plc (NYSE: AGN) today announced that its Board of Directors has declared a cash dividend of $0.74 per ordinary share for the second quarter...

Mar 10, 2020, 07:30 ET Announcement under the Irish Takeover Rules: Relevant Securities in Issue - March 10, 2020

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF...

Mar 05, 2020, 09:44 ET Allergan Receives FDA Approval for DURYSTA™ (bimatoprost implant) the First and Only Intracameral Biodegradable Sustained-Release Implant to lower Intraocular Pressure in Open-Angle Glaucoma or Ocular Hypertension Patients

Allergan plc (NYSE: AGN), a leading global pharmaceutical company with more than 70 years of heritage in eye care, today announced that the U.S. Food ...

Mar 03, 2020, 16:15 ET Announcement under the Irish Takeover Rules: Relevant Securities in Issue - March 3, 2020

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF...

Feb 25, 2020, 07:30 ET Allergan to Present New Data for Investigational Bimatoprost Sustained-Release at American Glaucoma Society Annual Meeting

Allergan plc, (NYSE: AGN), a leading global pharmaceutical company with a more than 70-year heritage in ophthalmology, will present new data from...

Feb 14, 2020, 16:15 ET Announcement under the Irish Takeover Rules: Relevant Securities in Issue - February 14, 2020

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF...

Feb 14, 2020, 07:00 ET Announcement under Rule 8.1(a) of the Irish Takeover Rules: Dealings by Offerors, Offerees or Parties Acting in Concert With Them for Themselves or for Discretionary Clients

Ap9 APPENDIX 3 DISCLOSURE FORMS FORM 8.1(a)&(b)(i) IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT,...

Feb 10, 2020, 07:00 ET Allergan Reports Fourth Quarter and Full-Year 2019 Financial Results

Allergan plc (NYSE: AGN) today reported its full-year and fourth quarter 2019 financial results including full-year 2019 GAAP net revenues of $16.1...

Feb 03, 2020, 07:30 ET BOTOX® Cosmetic (onabotulinumtoxinA) Launches Be The Difference Philanthropic Program

Allergan plc (NYSE: AGN) announced today its Be The Difference philanthropic program supporting children and their families who may benefit from...

Jan 31, 2020, 07:30 ET Allergan to Report Fourth Quarter and Full Year 2019 Financial Results

Allergan plc (NYSE: AGN) today announced it will release fourth quarter and full year 2019 financial results on Monday, February 10, 2020, prior to...

Jan 30, 2020, 16:15 ET Announcement under the Irish Takeover Rules: Relevant Securities in Issue - January 30, 2020

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF...

Jan 24, 2020, 07:00 ET Allergan Declares First Quarter 2020 Cash Dividend of $0.74 Per Ordinary Share

Allergan plc (NYSE: AGN) today announced that its Board of Directors has declared a cash dividend of $0.74 per ordinary share for the first quarter...

Jan 17, 2020, 07:30 ET SkinMedica® Launches New Instant Bright Eye Cream For Immediate, Visible Results

Allergan plc (NYSE: AGN) announced today the launch of the SkinMedica® Instant Bright Eye Cream, a refreshing eye treatment that hydrates, brightens...
Allergan Teams Up With Super Bowl MVP Von Miller to Raise Awareness of Glaucoma's Impact on Daily Living

Jan 16, 2020, 07:30 ET Allergan Teams Up With Super Bowl MVP Von Miller to Raise Awareness of Glaucoma's Impact on Daily Living

Allergan plc (NYSE: AGN), a leading global pharmaceutical company with more than 70 years of heritage in eye care, announced today a partnership with ...

Jan 06, 2020, 07:00 ET Warner Chilcott and Watson Resolve Antitrust Class Action Litigation with Direct and Indirect Purchasers of Loestrin 24 Fe and Minastrin 24 Fe

Allergan plc (NYSE: AGN), today announced that its Warner Chilcott and Watson subsidiaries have reached resolutions with all plaintiffs, including a...

Dec 23, 2019, 15:13 ET Allergan Receives U.S. FDA Approval for UBRELVY™ for the Acute Treatment of Migraine with or without Aura in Adults

Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for UBRELVY™...
Allergan Foundation Giving Reaches $95 Million Since Inception

Dec 19, 2019, 08:37 ET Allergan Foundation Giving Reaches $95 Million Since Inception

Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that The Allergan Foundation has awarded a total of $10 million in ...

Dec 16, 2019, 07:00 ET BOTOX® (onabotulinumtoxinA) Celebrates 30 Years of Endless Innovation

Allergan plc (NYSE: AGN) is commemorating today the beginning of the 30th anniversary celebration for BOTOX® this year with the ringing of the New...